Search Results - "Ogata, Ryosuke"

Primary Malignant Melanoma of the Esophagus Treated with Surgical Resection at an Early Stage.

Authors: Yoneda, Akira Ogata, Ryosuke Ryu, Shintaro et al.

Source: Case Reports in Gastroenterology. 2024, Vol. 18 Issue 1, p189-194. 6p.

Onset of pulmonary Epstein–Barr virus‐positive diffuse large B‐cell lymphoma in a patient with silicosis.

Authors: Ogata, Ryosuke Soda, Hiroshi Tanaka, Yasuhiro et al.

Source: Thoracic Cancer. Jan2022, Vol. 13 Issue 1, p133-136. 4p.

Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases.

Authors: Ogata, Ryosuke Soda, Hiroshi Senju, Hiroaki et al.

Source: Thoracic Cancer. Oct2022, Vol. 13 Issue 19, p2812-2816. 5p.

Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.

Authors: Tomono, Hiromi Taniguchi, Hirokazu Fukuda, Minoru et al.

Source: Thoracic Cancer. Oct2023, Vol. 14 Issue 28, p2890-2894. 5p.

Conformational changes in the catalytic region are responsible for heat-induced activation of hyperthermophilic homoserine dehydrogenase.

Authors: Kubota, Tatsuya Kurihara, Erika Watanabe, Kazuya et al.

Source: Communications Biology. 7/14/2022, Vol. 5 Issue 1, p1-7. 7p.

Subgrid Model of Water Storage in Paddy Fields for a Grid-Based Distributed Rainfall–Runoff Model and Assessment of Paddy Field Dam Effects on Flood Control.

Authors: Nihei, Yasuo Ogata, Yuki Yoshimura, Ryosuke et al.

Source: Water (20734441). Jan2024, Vol. 16 Issue 2, p255. 27p.

FEDERAL REGISTER.

Source: Federal Register (National Archives & Records Service, Office of the Federal Register). 7/21/2023, Vol. 88 Issue 139, pI-iii. 409p.

Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections.

Authors: Fukaya-Shiba A Ogata A Kuribayashi R et al.

Source: Frontiers in pharmacology [Front Pharmacol] 2025 Dec 18; Vol. 16, pp. 1713471. Date of Electronic Publication: 2025 Dec 18 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

Authors: Dotsu, Yosuke Yamaguchi, Hiroyuki Fukuda, Minoru et al.

Source: Journal of Clinical Medicine. Sep2021, Vol. 10 Issue 18, p4221. 1p.